Search results for: 'API industry'

25 Jul 2016  |  Europe  |  Market Research

Analysis of the Global Biologics API Market

Redefining the Future of Biologics through Target-specific Drugs and Novel Technologies

Infographics

×

This study provides an insight into the global biologics active pharmaceutical ingredients (API) market. According to the US FDA, “Biological products, or biologics, are medical products made from a variety of natural sources (human, animal, or microorganism). Biologics are intended to treat diseases & medical conditions and prevent or diagnose dis...

As the energy transition gathers pace in Europe, market evidence and the growth trajectory of alternative/low-carbon hydrogen point to a niche market opportunity where production and offtake will likely be dominated by traditional hydrogen consumption industries, including refining, chemicals, and petrochemicals, as well as heavy industrial sectors...

Increasing focus by end-users on reliability and safety is expected to mobilise the industrial compressor services market. Repairs and maintenance activities have assumed greater significance post the 2008-09 economic recession, which diminished the capital expenditure for new projects. The impact of European Union sanctions (on account of the geo-...

This Frost & Sullivan research service analyzes the global industrial automation market from 2020 to 2025, with 2020 as the base year. The deliverable offers an in-depth look at the dynamics influencing and challenging the growth of the industrial automation market and analyzes the process automation technology segments across process, discrete, an...

This growth insight explores opportunities for process equipment companies in the European region. It provides an analysis of how the landscape in the commodity chemicals industry is changing and will impact the market. Opportunities in terms of the investment/CAPEX scenarios, boom in the bio-based economy, rising focus on "plug and produce" manufa...

Europe’s life sciences sector is approaching a defining inflection point in 2026, as major regulatory and policy reforms converge to reshape pharma, diagnostics, life sciences IT, biotechnology, and the bioeconomy. Together, these frameworks open clear growth pathways across the value chain: the Clinical Trials Regulation (CTR) and European Health ...

Per- and polyfluoroalkyl substances (PFAS) present substantial environmental and health risks. Their complex structure makes them resistant to natural breakdown and allows them to accumulate in living organisms, posing a potential health risk. Growing evidence of PFAS contamination in surface water, groundwater, wastewater, soil, and air is compell...

In 2022, above-the-neck PPE generated revenue of €665.0 million in E. In addition to the growing demand for lightweight and comfortable products, the push for PPE products made from sustainable products and processes will ensure high growth rates across segments. Eye protection, the largest above-the-neck PPE product segment is set to witness a hi...

As the European economy continues to suffer, growth, competitiveness, and digital resilience are top of mind for enterprises in the region. Cloud and the Internet of Things remain the foundational technologies powering digital transformation in European enterprises. Since 2010, Frost & Sullivan has conducted an annual survey of IT and business d...